title: [Ritonavir-boosted lopinavir monotherapy due to intolerance to nucleoside reverse transcriptase inhibitors in an HIV-infected paediatric patient].
authors.forename: María
authors.initials: M
authors.lastname: Espiau
authors.forename: Pere
authors.initials: P
authors.lastname: Soler-Palacín
authors.forename: Anna
authors.initials: A
authors.lastname: Borrull
authors.forename: Concepció
authors.initials: C
authors.lastname: Figueras
mesh_terms: D000293:Adolescent; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002653:Child Behavior Disorders / Q000139:chemically induced; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics; D004359:Drug Therapy, Combination; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D015658:HIV Infections / Q000151:congenital / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D054303:HIV Reverse Transcriptase / Q000235:genetics; D006801:Humans; D007669:Kidney Calculi / Q000139:chemically induced; D061466:Lopinavir; D008297:Male; D020125:Mutation, Missense; D011744:Pyrimidinones / Q000008:administration & dosage / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D019438:Ritonavir / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D018894:Reverse Transcriptase Inhibitors; D061466:Lopinavir; C514824:reverse transcriptase, Human immunodeficiency virus 1; D054303:HIV Reverse Transcriptase; D019438:Ritonavir